SB
Serge Belanger Needham Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
119
Avg Return
Past Year
Past Year
7.4%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
82.4%
Neutral
17.6%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Hold
Reiterated
| – | – | 2 | – |
–
| 15 Oct ‘25 4 days ago |
|
|
|
Buy
Maintained
| $20 |
202%
upside
| 2 | +1% |
0
%
| 15 Oct ‘25 4 days ago |
|
|
|
Buy
Maintained
| $20 |
69%
upside
| 2 | +12% |
0
%
| 1 Oct ‘25 18 days ago |
|
|
|
Buy
Maintained
| $20 |
119%
upside
| 1 | -11% |
0
%
| 30 Sep ‘25 19 days ago |
|
|
|
Buy
Reiterated
| $28 |
152%
upside
| 1 | +5.5% |
0
%
| 12 Sep ‘25 1 month ago |
|
|
|
Buy
Reiterated
| $72 |
23%
upside
| 1 | +5.9% |
0
%
| 2 Sep ‘25 1 month ago |
|
|
|
Buy
Initiated
| $36 |
66%
upside
| 1 | +24% |
0
%
| 27 Aug ‘25 1 month ago |
|
|
|
Buy
Upgraded
| $36 |
51%
upside
| 1 | -13% |
0
%
| 12 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $36 |
60%
upside
| 1 | +10% |
0
%
| 12 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $3 |
133%
upside
| 1 | +5.2% |
0
%
| 8 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $22 |
112%
upside
| 1 | +21% |
0
%
| 8 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $22 |
5%
upside
| 1 | +14% |
0
%
| 7 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $34 |
40%
upside
| 1 | +4% |
0
%
| 6 Aug ‘25 2 months ago |
|
|
|
Hold
Downgraded
| $22 |
244%
upside
| 1 | +0.79% |
0
%
| 6 Aug ‘25 2 months ago |
|